Back to Blog

Alpha-Ketoglutarate: TCA Cycle Support and Longevity Evidence

February 26, 2026·4 min read

Alpha-ketoglutarate (AKG), also known as 2-oxoglutarate, is an intermediate in the Krebs (TCA) cycle—the central metabolic pathway that generates energy in mitochondria. For decades it was studied primarily in clinical nutrition for its role in protein metabolism and wound healing. More recently, it has attracted intense longevity research attention after a mouse study showed AKG supplementation extended healthy lifespan and a human trial found it reduced biological age by nearly two years. The mechanisms are now being unpacked, and they are more interesting than simple metabolic support.

AKG and the TCA Cycle

The TCA cycle produces NADH and FADH2, which feed the electron transport chain to generate ATP. AKG sits at a critical branch point: it is the product of isocitrate dehydrogenase action and the substrate for alpha-ketoglutarate dehydrogenase. AKG levels reflect the overall metabolic state of the cell and decline substantially with age—by some estimates, blood AKG levels drop tenfold between young adulthood and old age.

Beyond its role as an energy intermediate, AKG is a required cofactor for a large class of enzymes called alpha-ketoglutarate-dependent dioxygenases. These enzymes include TET enzymes (which regulate DNA methylation) and histone demethylases (which regulate chromatin structure). Both are central to epigenetic regulation—the process by which gene expression is controlled without changes to DNA sequence.

Epigenetic and Anti-Aging Mechanisms

The epigenetic connection is why AKG has become interesting to longevity researchers. TET enzymes use AKG to demethylate DNA; when AKG levels are adequate, TET enzymes maintain a healthy epigenetic landscape. As AKG declines with age, TET activity falls, DNA methylation patterns drift, and the epigenetic clock advances. Supplementing AKG may help maintain TET enzyme activity and slow epigenetic aging.

A 2023 randomized controlled trial in humans aged 60 years and older found that calcium AKG supplementation (1,000 mg/day) for seven months reduced biological age as measured by the Horvath epigenetic clock by an average of 1.8 years compared to placebo. This is the kind of result that captures attention—a direct reduction in measurable biological age in a human RCT. The trial was small (n=42), and replication in larger cohorts is needed, but the mechanistic rationale is solid.

mTOR Inhibition

AKG also inhibits mTOR (mechanistic target of rapamycin), the nutrient-sensing kinase that, when chronically overactive, accelerates aging. AKG signals cellular energy sufficiency to upstream regulatory pathways while simultaneously limiting mTOR activity—a somewhat paradoxical combination that may reflect its role as both an energy substrate and a signaling molecule. In C. elegans, AKG extended lifespan specifically through mTOR inhibition, not simply through enhanced ATP production.

Practical Dosing

The human RCT used calcium alpha-ketoglutarate at 1,000 mg/day (approximately 600 mg AKG). Other studies have used 1,000-3,000 mg/day. AKG is available as the calcium salt (CaAKG) or as arginine alpha-ketoglutarate (AAKG), a form popular in sports nutrition. CaAKG is preferred for longevity applications because AAKG's high arginine content may not be desirable in aging individuals with certain vascular conditions. AKG is best taken between meals to minimize competition with dietary amino acids for absorption.

FAQ

How does AKG compare to other longevity supplements? AKG is notable because it has a human RCT showing reduced biological age—something most longevity supplements lack. Its mechanisms (TCA cycle support, TET enzyme cofactor, mTOR inhibition) are distinct from NAD+ precursors, senolytics, or sirtuin activators, making it a potentially complementary addition to a longevity stack.

Can AKG replace a ketogenic diet or fasting? No. AKG provides some metabolic overlap with ketosis and fasting by supporting mitochondrial function and inhibiting mTOR, but these interventions have far broader effects. AKG should be viewed as a complement to, not a replacement for, diet and lifestyle interventions.

Is calcium AKG safe long-term? Available data suggests good tolerability. Some people report GI discomfort at higher doses, which is typically managed by taking with food. Long-term safety data beyond one year in humans is limited.

Related Articles

Track your supplements in Optimize.

Want to optimize your health?

Create your free account and start tracking what matters.

Sign Up Free